ANGLE (LON:AGL) Shares Up 14.3% – Still a Buy?

Shares of ANGLE plc (LON:AGL) shot up 14.3% on Tuesday . The company traded as high as GBX 12.99 ($0.16) and last traded at GBX 12.58 ($0.16). 1,308,476 shares changed hands during mid-day trading, an increase of 96% from the average session volume of 666,717 shares. The stock had previously closed at GBX 11 ($0.14).

Analysts Set New Price Targets

Separately, Berenberg Bank reiterated a “buy” rating and set a GBX 70 ($0.86) price objective on shares of ANGLE in a report on Thursday, September 26th.

ANGLE Price Performance

The company has a debt-to-equity ratio of 17.22, a quick ratio of 6.18 and a current ratio of 5.19. The firm has a fifty day simple moving average of GBX 10.70 and a 200 day simple moving average of GBX 11.22. The company has a market capitalization of £38.70 million, a PE ratio of -171.43 and a beta of 0.22.

About ANGLE

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.